Management of hypothalamic disease in patients with craniopharyngioma
Open accessThe DOI matches its Crossref record; 19 of the 19 references it cites were found in a registry or an index.
Abstract
Summary: Patients with craniopharyngioma experience excess morbidity and mortality when compared with the background population and with other hypopituitary patients. Large, suprasellar tumours which form micropapillae into surrounding structures can cause hypothalamic damage before any therapeutic intervention; attempted gross total resection can lead to hypothalamic obesity, sleep disorders, thirst disorders and dysregulation of temperature as well as panhypopituitarism. The management of tumour bulk and the pathophysiology of hypothalamic complications have been reviewed extensively. We present a practical, clinical approach to management of hypothalamic disease in a patient with craniopharyngioma and highlight potential targets for future pharmacological or surgical intervention.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Bhasin, S., Cunningham, G. R., Hayes, F. J., Matsumoto, A. M., Snyder, P. J., Swerdloff, R. S., & Montori, V. M. (2010) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-2354 · Cited by 1,954
Craniopharyngiomas in children and adults: systematic analysis of 121 cases with long-term follow-up
Karavitaki, N., Brufani, C., Warner, J. T., Adams, C. B. T., Richards, P., Ansorge, O., Shine, B., Turner, H. E., & Wass, J. A. H. (2005) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2005.02231.x · Cited by 633
Karavitaki, N., Cudlip, S., Adams, C. B. T., & Wass, J. A. H. (2006) · Endocrine Reviews · doi:10.1210/er.2006-0002 · Cited by 514
Mortality in Patients with Pituitary Disease
Sherlock, M., Ayuk, J., Tomlinson, J. W., Toogood, A. A., Aragon-Alonso, A., Sheppard, M. C., Bates, A. S., & Stewart, P. M. (2010) · Endocrine Reviews · doi:10.1210/er.2009-0033 · Cited by 392
Müller, H. L., Emser, A., Faldum, A., Bruhnken, G., Etavard-Gorris, N., Gebhardt, U., Oeverink, R., Kolb, R., & Sörensen, N. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-031751 · Cited by 287
Harz, K. J., Müller, H. L., Waldeck, E., Pudel, V., & Roth, C. (2003) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2002-021797 · Cited by 214
Hannon, M. J., Crowley, R. K., Behan, L. A., O'Sullivan, E. P., O'Brien, M. M. C., Sherlock, M., Rawluk, D., O'Dwyer, R., Tormey, W., & Thompson, C. J. (2013) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2013-1555 · Cited by 184
Self-citationMüller, H. L., Handwerker, G., Gebhardt, U., Faldum, A., Emser, A., Kolb, R., & Sörensen, N. (2006) · Cancer Causes & Control · doi:10.1007/s10552-005-9012-7 · Cited by 127
Agha, A., Walker, D., Perry, L., Drake, W. M., Chew, S. L., Jenkins, P. J., Grossman, A. B., & Monson, J. P. (2007) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2006.02688.x · Cited by 113
Hamilton, J., Conwell, L., Syme, C., Ahmet, A., Jeffery, A., & Daneman, D. (2011) · International Journal of Pediatric Endocrinology · doi:10.1155/2011/417949 · Cited by 109 · cited 1×
“…3 HO) Exenatide GLP1 analogue 1 d/c; mean 12.8% weight loss in CP Lomenick 2016 6 CP (& 4 HO) Exenatide GLP1 analogue 2 d/c; 6 stable/decreased weight Hamilton 2011 9 CP (teens) Diazoxide and metformin × 6/12 Insulin reduction & sensitization 2 d/c; mean BMI dec −0.3 ± 2.3 vs +2.2 ± 1.5 kg/m2 in…”
InfluentialMorbidity and mortality in patients with craniopharyngioma after surgery
Crowley, R. K., Hamnvik, O. P., O’Sullivan, E. P., Behan, L. A., Smith, D., Agha, A., & Thompson, C. J. (2010) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2010.03838.x · Cited by 108
Self-citationCrowley, R. K., Argese, N., Tomlinson, J. W., & Stewart, P. M. (2014) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2014-2476 · Cited by 97
Semiquantitative analysis of hypothalamic damage on MRI predicts risk for hypothalamic obesity
Roth, C. L., Eslamy, H., Werny, D., Elfers, C., Shaffer, M. L., Pihoker, C., Ojemann, J., & Dobyns, W. B. (2015) · Obesity · doi:10.1002/oby.21067 · Cited by 96
Müller, H. L. (2010) · International Journal of Endocrinology · doi:10.1155/2010/519607 · Cited by 77
Behan, L. A., Sherlock, M., Moyles, P., Renshaw, O., Thompson, C. J. T., Orr, C., Holte, K., Salehmohamed, M. R., Glynn, N., Tormey, W., et al. (2015) · European Journal of Endocrinology · doi:10.1530/eje-14-0719 · Cited by 75
Self-citationHammarstrand, C., Ragnarsson, O., Hallén, T., Andersson, E., Skoglund, T., Nilsson, A. G., Johannsson, G., & Olsson, D. S. (2017) · European Journal of Endocrinology · doi:10.1530/eje-17-0340 · Cited by 70
Crowley, R. K., Woods, C., Fleming, M., Rogers, B., Behan, L. A., O’Sullivan, E. P., Kane, T., Agha, A., Smith, D., Costello, R. W., et al. (2011) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2011.03993.x · Cited by 50
Self-citationvan Santen, H. M., Schouten-Meeteren, A. Y., Serlie, M., Meijneke, R. W. H., van Trotsenburg, A. S., Verberne, H., Holleman, F., & Fliers, E. (2015) · Journal of Pediatric Endocrinology and Metabolism · doi:10.1515/jpem-2014-0337 · Cited by 32
Fjalldal, S., Follin, C., Svärd, D., Rylander, L., Gabery, S., Petersén, Å., van Westen, D., Sundgren, P. C., Björkman-Burtscher, I. M., Lätt, J., et al. (2018) · European Journal of Endocrinology · doi:10.1530/eje-18-0081 · Cited by 31
Cited by
Diagnostic criteria for the hypothalamic syndrome in childhood
van Santen, H. M., van Schaik, J., van Roessel, I. M. A. A., Beckhaus, J., Boekhoff, S., & Müller, H. L. (2023) · European Journal of Endocrinology · doi:10.1093/ejendo/lvad009 · Cited by 67
Sleep Disorders in Patients With Craniopharyngioma: A Physiopathological and Practical Update
Romigi, A., Feola, T., Cappellano, S., De Angelis, M., Pio, G., Caccamo, M., Testa, F., Vitrani, G., Centonze, D., Colonnese, C., et al. (2022) · Frontiers in Neurology · doi:10.3389/fneur.2021.817257 · Cited by 28
Metadata
- Authors
- Thompson, C. J., Costello, R. W., & Crowley, R. K.
- Venue
- Clinical Endocrinology
- Publisher
- Wiley
- Published
- 2019-02-11
- Volume
- 90
- Issue
- 4
- Pages
- 506-516
- ISSN
- 0300-0664 (ISSN-L)
- 1365-2265
- OpenAlex
- W2907790042
- Cited by
- 48
- References
- 19
- FWCI
- 4.99
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.